Scientists launch Shs9.8 billion Crimean-Congo Hemorrhagic Fever vaccine study
Ugandan scientists have launched a Shs9.8 billion study to develop a vaccine for the deadly Crimean-Congo Hemorrhagic Fever (CCHF). The two-year study, which is already underway, is being conducted by researchers from the Uganda Virus Research Institute (UVRI) and the Medical Research
